Clinical Trial Update: Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ritonavir and its effects on biomarkers in women undergoing surgery for newly diagnosed breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ritonavir (Ritonavir)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED